Back to results
US 2021/0196670 A1Published application
Oral formulations of lavender and cannabinoids
AssigneeEmerald Health Therapeutics Canada Inc.
InventorsFreydoun GARABAGI, Nancy E. HARRISON, Salam A. KADHIM, Christopher WAGNER
Life of this patent
Estimating the term…
Abstract
Described herein are cannabinoid formulations in combination with lavender and/or a lavender extract for oral administration. Further described herein are methods for orally administering one or more cannabinoids to a subject in need thereof and manufacturing oral formulations as described herein.
Claims38
An oral formulation comprising:
- a. one or more cannabinoids selected from among the group consisting of:
- 0.1-750 mg tetrahydrocannabinolic acid (THCA),
- 0.1-100 mg tetrahydrocannabinol (THC),
- 0.1-750 mg cannabidiolic acid (CBDA),
- 0.1-750 mg cannabidiol (CBD),
- 0.1-750 mg cannabichromene (CBC), and
- 0.1-750 mg cannabigerol (CBG);
- and
- b. lavender and/or a lavender extract comprising a member from the group consisting of linalool, linalyl acetate, terpinen-4-ol, and camphor.
6 more elements
A method of preparing an oral formulation, the method comprising:
- a. preparing or obtaining a ground or milled Cannabis plant material preparation;
- b. passing the Cannabis plant material preparation through a mesh or sieve to obtain a retained fraction of the material which is retained in the mesh or sieve and a pass-through fraction of the material which has passed through the mesh or sieve;
- c. determining the content of the one or more cannabinoids of interest in the retained fraction and/or the pass-through fraction;
- d. based on the content determined in step (c), determining a target amount of retained fraction material, pass-through material, or a combination thereof, to be incorporated into the formulation such that the formulation includes the desired defined dose of the one or more desired cannabinoids;
- and
- e. combining the target amount of retained fraction material, pass-through material, or combination thereof with Lavender extract, thereby forming the formulation.
3 more elements
Dependencies are inferred from the claim text.